China SXT Pharmaceuticals SXTC Income Statement (2017-2026)

NASDAQ SXTC
$2.96 +0.15 (+5.34%)
As of: Sep 30, 2026 · 9:52 AM EDT
Reported Financials

China SXT Pharmaceuticals Quarterly Income Statement

Periods 10 quarters
Latest Mar 2026

China SXT Pharmaceuticals income statement data for the quarter ended Mar 2026. This income statement covers 10 quarters of results from Dec 2017 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Dec2017 Mar2018 Dec2018 Mar2019 Sep2023 Mar2024 Sep2024 Mar2025 Sep2025 Mar2026
Net income details
Consolidated Net IncomeConsol Net Inc. 1.19M-0.54M1.19M-1.17M
Income towards Parent CompanyParent Net Inc 1.19M-0.54M1.19M-1.17M
Net Income towards Common StockholdersNet Income 1.19M-0.54M1.19M-1.17M
Additional items
Shares Outstanding 0.00M0.00M0.00M0.00M0.00M0.01M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 0.01M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 0.01M0.01M

China SXT Pharmaceuticals Income Statement API

Pull China SXT Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SXTC&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY